Company: PCRX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001396814-25-000041
Chunk: 7

Company: Pacira BioSciences, Inc.
Filing Date: 2025-02-27
Form: 10-K
Item: Item 15
Chunk 7
---
 among the Registrant, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent.##8-K10.15/8/202410.57Executive Employment Agreement, dated May 4, 2020, by and between Pacira Pharmaceuticals, Inc. and Jonathan Slonin.***10-Q10.15/4/202210.58Amendment No. 1 to Executive Employment, dated as of October 31, 2024, by and between Pacira Pharmaceuticals, Inc. and Jonathan Slonin.***8-K10.211/6/202410.59Executive Employment Agreement, dated June 17, 2019, by and between Pacira Pharmaceuticals, Inc. and Daryl Gaugler.***10-Q10.15/3/202310.60Amendment No. 1 to Executive Employment Agreement, dated as of October 31, 2024, by and between Pacira Pharmaceuticals, Inc. and Daryl Gaugler.***8-K10.111/6/202410.61Form of Capped Call Transaction Confirmation.8-K10.15/14/202419Pacira BioSciences, Inc. Insider Trading Policy.*21.1Subsidiaries of the Registrant.*23.1Consent of KPMG LLP.*31.1Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a).*31.2Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a).*32.1Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**97Incentive Compensation Recovery Policy.***10-K972/29/2024

Pacira BioSciences, Inc.  |  2024 Annual Report on Form 10-K  |  Page 91

Incorporation By Reference FromExhibitNumberDescriptionFormExhibitDateFiled101.INS*Inline XBRL Instance Document.*101.SCH*Inline XBRL Taxonomy Schema Document.*101.CAL*Inline XBRL Taxonomy Calculation Linkbase Document.*101.LAB*Inline XBRL Taxonomy Label Linkbase Document.*101.PRE*Inline XBRL Taxonomy Presentation Linkbase Document.*101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.*104*